Radiation-based approaches to the management of T3 prostate cancer

Seminars in Urologic Oncology

Volumn 15, Issue 4, 1997, Pages 230-238

  Zietman, A L ^a   Westgeest, J C M ^a   Shipley, W U ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Androgen deprivation; Conformal therapy; Prostate cancer; Radiation

Indexed keywords

CYPROTERONE ACETATE; FLUTAMIDE; GOSERELIN; PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

ANDROGEN ANTAGONISTS; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030657758     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)